• Effect of angiotensin converting enzyme inhibitors on health related quality of life in Libyan patients with hypertension
    on October 11, 2021 at 12:00 am

    Effect of angiotensin converting enzyme inhibitors on health related quality of life in Libyan patients with hypertension Habib, Hana A.; . Alshami, Hiba A; Boamoud, Esraa S.; Tashani, Haneen A.; Shalgami, Salsabil G. Hypertension is a public health issue that significantly increases the risk of health problems and decreases health quality of life of the patients. Angiotensin converting enzyme inhibitors are used to control hypertension by preventing production of angiotensin II in turn decrease blood pressure, thus it may enhance the quality of life. This study aims to assess the effect of angiotensin converting enzyme inhibitors on the quality of life of patients with hypertensive aging 40 years or older in Benghazi city in comparison with other classes of hypertension medications. A case control observational study was conducted, adopting the structured face-to-face interviewing survey technique. Over 150 patients who visited Benghazi medical center during the study period (November, 2019 to March, 2020), to follow up their chronic disease. The investigators used a pre-validated, pre-piloted questionnaire that has been adopted from SF 36 and modified according to the updated literature review; responses to each question were coded and analyzed. The results display that antihypertensive medications were found to be significantly related to the limitation on the physical activity domain and found that medications decrease the limitation on the activity with about 20% of the patients who taking angiotensin receptor blockers (20%) and 30% of the patients taking angiotensin converting enzyme inhibitors, 40% of the patients had no limitations on bending kneeling and stooping. Moreover, on the limitations on walking more than one kilometre, the results were about 15% of the patients taking angiotensin receptor blockers and 30% of the patients taking angiotensin converting enzyme inhibitors had a slightly or no limitation on walking more than a kilometre. Thus, the findings indicate that antihypertensive medications have a positive effect on quality of life of the patient in limitation on activity domain but no conclusive difference was found between angiotensin converting enzyme inhibitors and angiotensin receptor blockers medications.

  • THE DIFFERENCE BETWEEN THE REPORTS FROM ASTHMATIC CHILDREN AND THEIR PARENTS ABOUT THE EFFECT OF ASTHMA ON THEIR QUALITY OF LIFE IN PEDIATRIC HOSPITAL-BENGHAZI-LIBYA
    on July 3, 2021 at 12:00 am

    THE DIFFERENCE BETWEEN THE REPORTS FROM ASTHMATIC CHILDREN AND THEIR PARENTS ABOUT THE EFFECT OF ASTHMA ON THEIR QUALITY OF LIFE IN PEDIATRIC HOSPITAL-BENGHAZI-LIBYA Amraja, Essam; Buras Ali, Raja; Elsherif, Abdulnaser; SE Hussein, Maryam; Kattab, Hwuida Introduction: Childhood asthma is a serious health problem that results in impairment of physical and social life of the affected children. Objective: The current study identifies the effect of asthma on asthmatic children quality of life and also to assess the differences between child's and parents' report about the effect of the asthma on the child's physical health, child's emotional health and child's activity. Method: A cross-sectional, descriptive, quantitative study was carried out where about Sixty-four participants of asthmatic children with their parents that were attached at Pediatric Hospital in Benghazi have been recruited and asked to complete Children of Health Survey for Asthma (CHSA) instruments. Results and Conclusion: The results showed that asthma relatively affects children’s physical health, activities and emotional health. Also, the results showed that there were significant differences in child's and parent report regarding the effect of asthma in child's quality of life.

  • EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS
    on May 8, 2021 at 12:00 am

    EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS . Hussin, Hanin F; Mohamed, Iman E; Alobidy, Sanad W.; Bosafita, Fatma M Context: Metformin is the first line treatment in type II diabetes mellitus. In addition, it was used for weight reduction in both diabetic and non-diabetic obese patients. Aims: The aim of this study was to examine the efficacy of metformin in weight reduction among diabetic and non-diabetic obese patient in Benghazi, Libya. Settings and Design: a cross-sectional study Methods and Material: A hundred well-designed a cross-sectional survey was distributed from January to December 2020 and filled by diabetic and non-diabetic obese patients (66 and 34, respectively) in Benghazi city. Statistical analysis used: SPSS statistics soft wear (Version 21.0; SPSS Inc.: Chicago, IL, USA). Results: Results had shown that 66.7 % of diabetic obese patients were more than 50 years while 35.5 % of non- diabetic obese patients were 21-25 years. 1-5 kg was the weight reduction in both diabetic and non- diabetic obese patients (43.9 % and 38.2 %, respectively) Conclusions: According to this study, metformin is an effective therapy to reduce weight in diabetic and non-diabetic obese patients. Further studies are needed with exact weight reduction.

  • The First PharmD Program in Libya
    on July 6, 2019 at 12:00 am

    The First PharmD Program in Libya Bukhatwa, Salma; Elfakhri, Mustafa